Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Nonprofit Medicines360 Provides Affordable Contraception, Women’s Health

Executive Summary

Emerging Company Profile: Medicines360 and partner Allergan launched the IUD Liletta in 2015, so now the nonprofit pharmaceutical company is looking for additional contraceptives and women’s health products.

You may also be interested in...

Keeping Track: New Indication For Lucentis; New Lesinurad Application From Ironwood

The latest drug development news and highlights from our FDA Performance Tracker.

Women's Health a priority for new Allergan

Long-Acting Reversible Contraceptives Await “Obamacare” Boost

Contraception coverage mandated by the Affordable Care Act could unlock demand for IUDs. Actavis aims to provide an alternative to Bayer’s hormone-eluting IUD in 2014; public sector rights to Levosert are assigned to nonprofit Medicines360.

Related Content


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts